The newly approved linvoseltamab (Lynozyfic; Regeneron) has a manageable safety profile, along with a patient-friendly dosing schedule that includes intravenous administration, step-up dosing, and ...

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Median progression-free survival was 3.7 months, with 44.4% of patients being progression free at 6 months and 32.3% at 12 ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

The going has been good for the German pharmaceutical giant Bayer BAYRY this year. Shares have surged 62.9% year to date ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

As Boston Scientific gears up for its upcoming earnings release on July 23, the market is ripe with anticipation. Analysts, armed with revised forecasts, project a robust year-over-year increase in ...

The US Food and Drug Administration granted clearances for infectious disease tests, digital pathology software, and hematology analyzers, among other in vitro diagnostic technologies.